<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18354">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01958710</url>
  </required_header>
  <id_info>
    <org_study_id>ASPERLEU</org_study_id>
    <nct_id>NCT01958710</nct_id>
  </id_info>
  <brief_title>Outcome After Treatment of Pulmonary Aspergilloma</brief_title>
  <official_title>Outcome After Surgical Treatment or Bronchial Embolisation in Aspergilloma of the Lung: a Single Center Experience.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gasthuisberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Gasthuisberg</source>
  <oversight_info>
    <authority>Belgium: Federal Agency for Medicines and Health Products, FAMHP</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective analysis of surgery and/or bronchial embolisation for pulmonary aspergilloma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A retrospective chart analysis, based on the search results from a thoracic surgery database
      and an interventional radiology database. Outcome analysis of all surgically treated
      patients for a confirmed invasive aspergilloma. Comparisson with (preoperative) embolisation
      of the bronchial circulation.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>survival after treatment</measure>
    <time_frame>10 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>estimated 10 yaer survival after treatment for pulmonary aspergilloma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>post treatment survival</measure>
    <time_frame>90 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>survival status at 90 days after initiation of treatment</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pulmonary Fungal Diseases</condition>
  <arm_group>
    <arm_group_label>Embolisation</arm_group_label>
    <description>(preoperative) embolisation of the bronchial circulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <description>Any surgically treated patient with a functional lung resection (at least wedge resection)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients in the database with following interventions will be screened for invasive
        aspergilloma in the final resection specimen:

        Aspergilloma Fungal disease Lung bleeding Destroyed lung Empyema of the lung
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histological proven Aspergilloma of the lung

        Exclusion Criteria:

          -  Treatment limited to the use of systemic antifungal agents
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Herbert Decaluw√©, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven - dept. Thoracic Surgery</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laurence Bertrand, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholic University Leuven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 7, 2013</lastchanged_date>
  <firstreceived_date>October 7, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Gasthuisberg</investigator_affiliation>
    <investigator_full_name>Johnny Moons</investigator_full_name>
    <investigator_title>Datamanager Thoracic Surgery</investigator_title>
  </responsible_party>
  <keyword>Catheterization, Bronchial</keyword>
  <keyword>Pneumonectomy</keyword>
  <keyword>Lobectomy</keyword>
  <keyword>Thoracoplasty</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Diseases, Fungal</mesh_term>
    <mesh_term>Mycoses</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
